Veteran growth-stage investor and operator concentrating on technology and consumer sectors, Jeff Kautz leverages cross-border deal experience and operational leadership to source and scale high-growth companies. He combines prior operating roles with private equity and venture investing, focusing on revenue acceleration, commercial strategy, and board governance. Market-facing profile emphasizes hands-on portfolio support, follow-on capital coordination and exit readiness for institutional LPs and strategic acquirers.
Veteran growth-stage investor and operator concentrating on technology and consumer sectors, Jeff Kautz leverages cross-border deal experience and operational leadership to source and scale high-growth companies. He combines prior operating roles with private equity and venture investing, focusing on revenue acceleration, commercial strategy, and board governance. Market-facing profile emphasizes hands-on portfolio support, follow-on capital coordination and exit readiness for institutional LPs and strategic acquirers.
Focuses on growth-stage technology and consumer opportunities, deploying capital and operational leadership to accelerate revenue, commercial go-to-market and unit economics. Prefers concentrated, hands-on investments with board-level governance, milestone-based follow-on funding and cross-border exit pathways. Underwrites deals for scalable repeatability, prioritizing companies with clear distribution leverage, measurable KPIs and path-to-profitability over a multi-year scaling horizon.
Focuses on growth-stage technology and consumer opportunities, deploying capital and operational leadership to accelerate revenue, commercial go-to-market and unit economics. Prefers concentrated, hands-on investments with board-level governance, milestone-based follow-on funding and cross-border exit pathways. Underwrites deals for scalable repeatability, prioritizing companies with clear distribution leverage, measurable KPIs and path-to-profitability over a multi-year scaling horizon.
| Trades 632 | Longs Won 335/632 53% | Profit Factor 1.53 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $168,630.95 |
| Average Win $78,289.1 | Best Trade (Mar 30) $1.39M | Sharpe Ratio -14.47 |
| Average Loss -$57,837.72 | Worst Trade (Sep 29) -$1.12M | Z-Score 1.73 (91.63%) |
| Commissions $0 | Avg. Trade Length 1y 4m 4d | Expectancy $14,318.11 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.03% |
| Consecutive Losing Trades | 1,323 | 1,190 | 1,058 | 926 | 794 | 661 | 529 | 397 | 265 | 132 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ABM ABM Industries Inc. | 21,252 | $953,405.66 | $1.02M | - | $64,777.66 | 6.79% | +0.651% |
ADUS Addus HomeCare Corporation | 7,396 | $687,242.91 | $854,090.08 | - | $166,847.17 | 24.28% | -1.028% |
AEIS Advanced Energy Industries Inc. | 4,027 | $437,609.65 | $1.17M | - | $728,287.35 | 166.42% | +5.564% |
ALG Alamo Group Inc. | 5,156 | $1.08M | $820,216.49 | - | -$263,746.66 | -24.33% | +0.786% |
ASTH Astrana Health Inc. | 29,786 | $1.14M | $1.06M | - | -$79,637.88 | -6.99% | -3.053% |
ATEN A10 Networks, Inc. | 43,965 | $797,964.85 | $1.3M | - | $502,080.2 | 62.92% | -1.269% |
AWR American States Water Co. | 10,039 | $807,117.51 | $859,739.96 | - | $52,622.45 | 6.52% | -0.372% |
BAH Booz Allen Hamilton Holding Corporation | 2,949 | $360,218.41 | $205,604.28 | - | -$154,614.13 | -42.92% | +2.064% |
BR Broadridge Financial Solutions, Inc. | 1,283 | $264,079.19 | $197,517.85 | - | -$66,561.34 | -25.21% | -0.53% |
BRC Brady Corporation | 18,876 | $1.11M | $1.78M | - | $669,639.3 | 60.34% | +1.213% |
BRKR Bruker Corporation | 18,063 | $744,195.93 | $1.14M | - | $390,882.99 | 52.52% | -2.331% |
CBT Cabot Corporation | 10,831 | $812,326.05 | $953,344.59 | - | $141,018.54 | 17.36% | -0.238% |
CF CF Industries Holdings, Inc. | 3,192 | $255,333.64 | $399,606.48 | - | $144,272.84 | 56.5% | -0.461% |
CGNX Cognex Corporation | 18,944 | $679,331.99 | $1.24M | - | $556,574.57 | 81.93% | +4.184% |
CHD Church & Dwight Co., Inc. | 2,849 | $238,889 | $281,509.69 | - | $42,620.69 | 17.84% | +1.157% |
CHE Chemed Corporation | 2,192 | $981,445.96 | $1.17M | - | $185,246.04 | 18.87% | -0.475% |
CNS Cohen & Steers Inc. | 13,074 | $991,980.32 | $1.08M | - | $83,617.66 | 8.43% | +0.858% |
CPAY Corpay, Inc. | 843 | $259,854.75 | $322,118.72 | - | $62,263.97 | 23.96% | -2.053% |
CPRT Copart Inc. | 6,758 | $264,576 | $196,792.96 | - | -$67,783.04 | -25.62% | -1.522% |
CPRX Catalyst Pharmaceuticals Inc. | 36,010 | $557,996.93 | $1.13M | - | $575,957.97 | 103.22% | 0.0 |